The effect of heavy metals on nicotinamide N-methyltransferase activity in vitro relating to Parkinson's disease

Environmental Health and Preventive Medicine

Volumn 10, Issue 4, 2005, Pages 180-183

  Sugawara, Akiko ^a   Yokoyama, Hiroko ^a   Ohta, Mitsuhiro ^a   Maeda, Takafumi ^a   Tanaka, Kazuko ^a   Fukushima, Tetsuhito ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Heavy metal; Nicotinamide N methyltransferase; Parkinson's disease; Sulfhydryl group

Indexed keywords

CADMIUM; COPPER; HEAVY METAL; IRON; MANGANESE; NICOTINAMIDE METHYLTRANSFERASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CENTRIFUGATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; KIDNEY HOMOGENATE; LIVER HOMOGENATE; MALE; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; RAT; SUPERNATANT;

ANIMALIA; RATTUS NORVEGICUS;

EID: 24944539173     PISSN: 1342078X     EISSN: None     Source Type: Journal    
DOI: 10.1265/ehpm.10.180     Document Type: Article

References (23)

1. Couper J. On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharm. 1837; 1: 41-42.
2. Takeda A. Manganese action in brain function. Brain Res Brain Res Rev. 2003; 41: 79-87.
3. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, et al. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology. 1997; 48: 650-658.
4. Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, et al. Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology. 2003; 60: 1761-1766.
5. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983; 219: 979-980.
6. Gearhart DA, Neafsey EJ, Collins MA. Characterization of brain β-carboline-2-N-methyltransferase, an enzyme that may play a role in idiopathic Parkinson's disease. Neurochem Res. 1997; 22: 113-121.
7. Kotake Y. Tetrahydroisoquinoline derivatives as possible Parkinson's disease-inducing substances. Yakugaku Zasshi. 2002; 122: 975-982. (Article in Japanese)
8. Mizuno Y, Sone N, Saitoh T. Effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain. J Neurochem. 1987; 48: 1787-1793.
9. Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, et al. Deficiencies in complex I subunits of the respiratory chain in parkinson's disease. Biochem Biophys Res Commun. 1989; 163: 1450-1455.
10. Parker WD Jr, Boyson SJ, Parks JK. Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann Neurol. 1989; 26: 719-723.
11. Schapira AH, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, et al. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem. 1990; 55: 2142-2145.
12. Williams AC, Pall HS, Steventon GB, Green S, Buttrum S, Molloy H, et al. N-methylation of pyridines and Parkinson's disease. Adv Neurol. 1993; 60: 194-196.
13. Parsons RB, Smith ML, Williams AC, Waring RH, Ramsden DB. Expression of nicotinamide N-methyltransferase (E.C.2.1.1.1) in the Parkinsonian brain. J Neuropathol Exp Neurol. 2002; 61: 111-124.
14. Fukushima T, Tawara T, Isobe A, Hojo N, Shiwaku K, Yamane Y. Radical formation site of cerebral complex I and Parkinson's disease. J Neurosci Res. 1995; 42: 385-390.
15. Fukushima T, Kaetsu A, Lim H, Moriyama M. Possible role of 1-methylnicotinamide in the pathogenesis of Parkinson's disease. Exp Toxicol Pathol. 2002; 53: 469-473.
16. Sano A, Endo N, Takitani S. Fluorometric assay of rat tissue N-methyltransferases with nicotinamide and four isomeric methylnicotinamides. Chem Pharm Bull. 1992; 40: 153-156.
17. 1-methylnicotinamide, an endogenous marker of renal cationic transport and plasma flow. J Pharm Biomed Anal. 2001; 4: 391-404.
18. Zhang S, Zhou Z, Fu J. Effect of manganese chloride exposure on liver and brain mitochondria function in rats. Environ Res. 2003; 93: 149-157.
19. Hanahisa Y, Yamaguchi M. Inhibitory effect of zinc and copper on phosphatase activity in the brain cytosol of rats: involvement of SH groups. Biol Pharm Bull. 1998; 21: 1222-1225.
20. Fukushima T. Niacin metabolism and Parkinson's disease. Environ Health Prev Med. 2005; 10: 3-8.
21. Bandyopadhyay D, Chatterjee AK, Datta AG. Effect of cadmium, mercury and copper on partially purified hepatic flavokinase of rat. Mol Cell Biochem. 1997; 167: 73-80.
22. Upmeier B, Gross W, Koster S, Barz W. Purification and properties of S-adenosyl-L-methionine:nicotinic acid-N-methyltransferase from cell suspension cultures of Glycine max L. Arch Biochem Biophys. 1988; 262: 445-454.
23. Aschner M. Manganese: brain transport and emerging research needs. Environ Health Perspect. 2000; 108 Supple 3: 429-432.